ArticleOncology letters2017
Aviscumine, a recombinant ribosomal inhibitor, increases the antitumor activity of natural killer cells.
Gabriele Gamerith et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it